Report overview from Medtech Insight - Published May 2008
Tissue-altering directed energy-based surgical systems utilizing cryogenic, laser, microwave, radiofrequency, or ultrasound technologies are widely used in an array of applications including aesthetic, cardiovascular, dental, gynecologic, oncologic, orthopedic, otorhinolaryngologic, and urologic surgical procedures. In 2007, approximately 16.2 million procedures involving directed energy-based surgical systems were performed in the U.S. Expanding at a compound annual rate of 7.4%, sales of directed energy-based surgical systems are projected to climb from approximately $3.1 billion in 2007 to an estimated $4.1 billion in the year 2011.
This new report from Medtech Insight presents analyses of products, current and emerging markets, competitors, and opportunities in the U.S. directed energy-based surgical systems market.
Major topics covered by this report include aesthetics applications of directed energy-based surgical systems including cellulite treatment and body contouring, cutaneous vascular lesion management, hair removal, and skin resurfacing and rejuvenation; cardiovascular applications such as atherectomy, catheter-based and surgical arrhythmia ablation, lead removal, peripheral endovascular therapies, stroke management, and transmyocardial revascularization; cosmetic, general, and periodontic dentistry applications; gynecologic applications including menorrhagia management utilizing minimally invasive treatment systems; ophthalmic applications including age related macular degeneration, cataract surgery, diabetic retinopathy, glaucoma management, retinal detachment management, and vision correction; orthopedic applications including laser-assisted spinal surgery and radiofrequency-based spinal surgery; otorhinolaryngologic applications such as ablation/excision of laryngeal lesions, myringotomy, sinus surgery, stapedectomy, tonsillectomy, turbinectomy, and uvula palatoplasty; urologic applications including benign prostatic hyperplasia management, cryotherapy, extracorporeal shockwave lithotripsy, intracorporeal lithotripsy, photoselective vaporization of the prostate, transurethral microwave thermotherapy, and transurethral needle ablation.
To read more about this report, including the table of contents and ordering information please visit Medtech Insight or contact [email protected]. From outside the U.S., contact [email protected]. You can also call 1.949.219.0150 (or toll-free within the U.S. at 1.888.290.2225) or fax 1.949.219.0067.
